Orchestra BioMed Holdings Inc. Cash Flow
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
2023
2022
2021
2020
-46M
-49M
0M
8M
-3M
-3M
11M
0M
46M
0M
-0 %
0M
0M
0M
31M
11M
20M
-46M
-2M
-3M
0M
3M
0M
2M
-64M
1M
-93M
0M
-0 %
-93M
0M
6M
0M
-2M
2M
-2M
-19M
-23M
0M
0M
0M
3M
13M
0M
-4M
0M
-0 %
0M
-4M
0M
10M
-10M
20M
-20M
-26M
-21M
0M
0M
3M
-8M
27M
1M
10M
0M
-0 %
0M
10M
-152M
20M
11M
10M
-27M
Concept
Operating Cash Flow
Net Income
Depreciation & Amortization
Stock based compensation
Other non cash items
Change in working capital
Investing Cash Flow
Capital Expenditures
Financing Cash Flow
Dividends Paid
Payout Ratio
Share Issuance / Repurchase
Debt Issued / Paid
Other Investing Activities
End Cash Position
Changes in Cash
Beginning Cash Position
Free Cash Flow
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
-11M
-13M
0M
1M
0M
0M
33M
0M
-11M
0M
-0 %
0M
0M
0M
31M
11M
19M
-11M
-10M
-13M
0M
4M
-1M
1M
13M
0M
0M
0M
-0 %
0M
0M
13M
19M
3M
16M
-10M
-10M
-12M
0M
2M
-1M
1M
8M
0M
0M
0M
-0 %
0M
0M
8M
16M
-2M
19M
-11M
-14M
-11M
0M
1M
-1M
-4M
-44M
0M
57M
0M
-0 %
0M
0M
57M
19M
-1M
20M
-14M
-9M
-10M
0M
1M
2M
0M
8M
0M
-5M
0M
-0 %
0M
0M
-5M
20M
-77M
97M
-9M
-1M
-1M
0M
2M
0M
0M
8M
0M
-93M
0M
-0 %
-93M
0M
93M
1M
-1M
1M
-1M
-8M
-8M
0M
0M
0M
-1M
0M
0M
86M
0M
-0 %
0M
0M
92M
107M
78M
29M
-8M
-5M
-6M
0M
0M
0M
0M
0M
0M
25M
0M
-0 %
0M
0M
26M
29M
19M
10M
-5M